Spatial analysis of factors impacting lower limb major amputation rates in Hungary
Is geography partially destiny?
Abstract
Summary:Background: Lower limb major amputations represent a substantial public health burden in Hungary, where previous research revealed markedly high rates with significant spatial variations. Therefore, we aimed to assess to what extent healthcare and socio-economic factors in the local environment explain the regional disparity. Patients and methods: In a retrospective cohort analysis, based on the healthcare administrative data of the Hungarian population, lower limb major amputations were identified from 1st of January 2017 to 31st of December 2019. The permanent residence of the amputees on the local administrative level (197 geographic units) was used to identify potential healthcare (outpatient care, revascularisation activity) and socio-economic (educational attainment, local infrastructure and services, income and employment) determinants of amputations. Spatial effects were modelled using the spatial Durbin error regression model. Results: 10,209 patients underwent 11,649 lower limb major amputations in the observational period. In our spatial analysis, outpatient care was not associated with local amputation rates. However, revascularisation activity in a geographic unit entailed an increased rate of amputations, while revascularisations in the neighbouring areas were associated with a lower rate of amputations, resulting in an overall neutral effect (β=−0.002, 95% CI: −0.05 – 0.04, p=0.96). The local socio-economic environment had a significant direct inverse association with amputations (β=−7.45, 95% CI: −10.50 – −4.42, p<0.0001) . Our spatial model showed better performance than the traditional statistical modelling (ordinary least squares regression), explaining 37% of the variation in amputations rates. Conclusions: Regional environmental factors explain a substantial portion of spatial disparities in amputation practice. While the socio-economic environment shows a significant inverse relationship with the regional amputation rates, the impact of the local healthcare-related factors (outpatient care, revascularisation activity) is not straightforward. Unravelling the impact of the location on amputation practice requires complex spatial modelling, which may guide efficient healthcare policy decisions.
References
1 . Diabetes-related amputations create considerable public health burden in the UK. Diabetes Res Clin Pract. 2018;135:158–65.
2 . Lower limb major amputation data as a signal of an east/west health divide across Europe. Eur J Vasc Endovasc Surg. 2020;60(5):645–6.
3 International variations in amputation practice: A VASCUNET Report. Eur J Vasc Endovasc Surg. 2018;56(3):391–9.
4 Lower limb amputations and revascularisation procedures in the Hungarian population: A 14 year retrospective cohort study. Eur J Vasc Endovasc Surg. 2020;59(3):447–56.
5 . Regional variation of lower limb major amputations on different geographic scales – a Hungarian nationwide study over 13 years. VASA. 2020;49(6):500–8.
6 Indicators of outcome quality in peripheral arterial disease revascularisations – a Delphi expert consensus. VASA. 2018;47(6):491–7.
7 . Current challenges and opportunities in the prevention and management of diabetic foot ulcers. Diabetes Care. 2018;41(4):645–52.
8 . Potentials, challenges, and limitations of the analysis of administrative data on vascular limb amputations in health care. VASA. 2020;49(2):87–97.
9 Reducing nontraumatic lower-extremity amputations by 20% by 2030: Time to get to our feet: A policy statement from the American Heart Association. Circulation. 2021;143(17):e875–91.
10 Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg. 2013;57(6):1471–9., 1480 e1471–3; discussion 1479–80.
11 . Lower limb amputation in England: prevalence, regional variation and relationship with revascularisation, deprivation and risk factors. A retrospective review of hospital data. J R Soc Med. 2014;107(12):483–9.
12 . Indicators for comparing the incidence of diabetic amputations: a nationwide population-based register study. Eur J Vasc Endovasc Surg. 2013;46(5):569–74.
13 Major amputations in type 2 diabetes between 2001 and 2015 in Spain: regional differences. BMC Public Health. 2020;20(1):54.
14 . Prevalence and regional distribution of lower limb amputations from 2006 to 2012 in Germany: a population based study. Eur J Vasc Endovasc Surg. 2015;50(6):761–6.
15 . Regional variation in the incidence of diabetes-related amputations in The Netherlands. Diabetes Res Clin Pract. 1996;31(1–3):125–32.
16 “No more amputations”: a complex scientific problem and a challenge for effective preventive strategy implementation on vascular field. Int Angiol. 2017;36(2):107–15.
17 Location, location, location: geographic clustering of lower-extremity amputation among Medicare beneficiaries with diabetes. Diabetes Care. 2011;34(11):2363–7.
18 Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg. 2013;57(6):1471–9., 1480.e1471–3; discussion 1479–80.
19 Relationship between regional spending on vascular care and amputation rate. JAMA Surg. 2014;149(1):34–42.
20 Spatial inequalities of major lower limb amputation rates in Paraná state, Brazil. BMJ Open. 2020;10(12):e038980.
21 . Health service organisation impact on lower extremity amputations in people with type 2 diabetes with foot ulcers: systematic review and meta-analysis. Acta Diabetol. 2021;58(6):735–47.
22 . The influence of socio-economic deprivation on mobility, participation, and quality of life following major lower extremity amputation in the west of Scotland. Eur J Vasc Endovasc Surg. 2019;57(4):554–60.
23 . Association of neighbourhood deprivation with risks of major amputation and death following lower limb revascularisation. Atherosclerosis. 2020;306:11–4.
24 . Geographic clustering of diabetic lower-extremity amputations in low-income regions of California. Health Aff. 2014;33(8):1383–90.
25 Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):e297.
26 The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.
27 . Regions in the European Union, Nomenclature of territorial units for statistics NUTS 2013/EU-28. Luxembourg: Publications Office of the European Union, 2015.
28 . OpenStreetMap Project. London: OpenStreetMap Foundation (OSMF). Available from https://data2.openstreetmap.hu/hatarok/index.php
29 . KSHStatinfoScraper. Available from https://github.com/tamas-ferenci/KSHStatinfoScraper
30 . Notes on continuous stochastic phenomena. Biometrika. 1950;37(1–2):17–23.
31 . What regional scientists need to know about spatial econometrics. Rev Reg Stud. 2014;44(1):13–32.
32 . How to interpret the coefficients of spatial models: Spillovers, direct and indirect effects. Spatial Demography. 2016;4(3):175–205.
33 . An introduction to spatial econometrics. Rev Écon Ind. 2008;123(3):19–44.
34 . Comparing implementations of global and local indicators of spatial association. TEST. 2018;27(3):716–48.
35 . Comparing implementations of estimation methods for spatial econometrics. J Stat Softw. 2015;63(18):1–36.
36 . A divide between the western European and the central and eastern European countries in the peripheral vascular field: A narrative review of the literature. J Clin Med. 2021;10(16):3553.
37 . The quality of care. How can it be assessed? JAMA. 1988;260(12):1743–8.
38 Regional health care services and rates of lower extremity amputation related to diabetes and peripheral artery disease: an ecological study. CMAJ Open. 2020;8(4):e659–66.
39 Development of administrative data algorithms to identify patients with critical limb ischemia. Vasc Med. 2014;19(6):483–90.
40 . Management of patients after endovascular interventions for peripheral artery disease. Circulation. 2013;128(7):749–57.
41 How could differences in “control over destiny” lead to socio-economic inequalities in health? A synthesis of theories and pathways in the living environment. Health Place. 2016;39:51–61.
42 . Impact of social determinants of health on cardiovascular disease prevention. Curr Opin Cardiol. 2021;36(5):572–9.
